A treatment for a major health problem may already be on the shelves of our pharmacies. Liver fibrosis is a condition that affects hundreds of millions of individuals and progresses silently ...

A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...

Cystic fibrosis causes a buildup of mucus in the lungs that can lead to infection, and often death in children and young ...

Vertex on track for “five launches in five disease areas over a five-year period” through emerging pain and renal franchises.

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

Vanzacaftor-tezacaftor-deutivacaftor, a novel therapeutic, once-daily drug, demonstrates noninferiority to elexacaftor-tezacaftor-ivacaftor (the twice-daily, standard-of-care drug) in lung function ...

The cost of medication was too high for thousands of CF sufferers around the world. Now a Bangladeshi company is making a generic version that will change lives ...

Animate Biosciences today announces positive preclinical results from a mouse model of pulmonary fibrosis demonstrating that ...

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung ...

EL PASO, Texas (KFOX14/CBS4) — Researchers at The University of Texas at El Paso are developing a new therapeutic approach that uses nanoparticles for the treatment of skin and lung fibrosis, ...